DUBLIN, Mar. 11, 2015 /PRNewswire/ –Research and Markets
( http://www.researchandmarkets.com/research/d96jd4/clinical) has announced the addition of the “Clinical Nutrition Products – Global Strategic Business Report” report to their offering.
This report analyzes the worldwide markets for Clinical Nutrition Products in US$ Million by the following Product Segments: Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East/ Africa, and Latin America.Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.The report profiles 64 companies including many key and niche players such as:- Abbott Nutrition- American HomePatient, Inc.- Baxter International, Inc.- B. Braun Melsungen AG- Claris Lifesciences Ltd.Key Topics Covered:1. INDUSTRY OVERVIEW
A Bird’s Eye View of the Clinical Nutrition Products Market
Emerging Markets: The New Hotspots for Growth
Infant Nutrition: Rapid Growth in Store
Infant Formula Market: Emerging Markets to Drive Growth
Competitive Landscape
Enteral Nutrition Market
Major Players in the Enteral Nutrition and Enteral Infant Nutrition Market
Parenteral Nutrition Market
Leading Players Operating in the Market for Parenteral Nutrition
Select Parenteral Nutrition Products by Company
2. MARKET DRIVERS, TRENDS & ISSUES
Impact of Recession in Retrospect and the Road Ahead
Improving Healthcare Expenditure to Drive Demand
Aging Population: A Strong Growth Driver
Rising Incidence of Chronic Diseases to Kindle Market Growth
World Cancer Statistics: Incidence and Mortality Data
Cancer Prone Sites based on Age
Diabetes Mellitus: Another Major Chronic Condition
Clinical Nutrition in Treatment of Malnutrition: Significant Growth Opportunities
Non-volitional Nutritional Support Therapy
Vital for Combating Malnutrition during Hospitalization
Shift towards Home Care Boosts Demand for Clinical Nutrition Products
Changing Health and Social Care Factors Favor Home Enteral Feeding
Rising Number of Premature Births Drives Infant Clinical Nutrition Products Market
Preterm Birth Statistics from WHO
Demand for Personalized Medicine to Bode Well for Clinical Nutrition Products Market
Product Innovations Blur the Lines between Medicine and Foods
Surging Demand for Omega-3 Fatty Acids-Fortified Clinical Nutrition Products
Advances in Enteral Feeding Devices: Positive Outlook for Enteral Nutrition Market
Rising Incidence of Pediatric Crohn’s Disease Fuels Enteral Nutrition Market
Specialized Formula Products Inundate the Market
Soy-based Infant Formula Gains Popularity
Pre-mixed IV Solutions: A Step towards Safer Medication Practices
Growing Demand for Low-Cost Parenteral Nutrition Solutions
Rising Preference for Multi-Chamber Bags to Lower Cost of Parenteral Nutrition Therapy
Increasing Popularity of Intravenous Vitamin C for Cancer Treatment
Infection Control: A Prime Concern in Parenteral Nutrition
Complacency of Hospitals & Worker/Patient Safety: A Key Issue
Favorable Clinical Findings Strengthens Prospects for Enteral Nutrition
Rising Preference for Enteral Nutrition
A Threat to Parenteral Nutrition Market
Advantages and Disadvantages of Enteral Nutrition over Parenteral Nutrition
Major Challenges Confronting Medical Nutrition Products’ Marketers
Barriers to Widespread Adoption of Clinical Nutrition Products
Reasons for Not Prescribing Clinical Nutrition Products
3. PRODUCT OVERVIEW
Clinical Nutrition: An Introduction
Diseases Indicating Administering of Clinical Nutrition
Advantages of Clinical Nutrition
Classification of Clinical Nutrition Products
Infant Nutrition Products
List of Infant Nutrition Products
Types of Infant Nutrition Products
Specialized Milk-Based Formulas
Soy-based Infant Formula
Amino Acid-based Formulas
Probiotic Infant Formulas
Prebiotics in Infant Nutrition
Exempt Infant Formulas
Human Milk Oligosaccharides
Nutrition Products for Preterm Infants
Premature Infant Formula
Transitional Formulas
Human Milk Fortifiers
Metabolic Infant Formulas
Follow-up or Follow-on Formulas
Enteral Administration of Infant Formulas in Neonatal Intensive Care and General Healthcare Settings
Nipple Feeding
Tube Feeding
Enteral Nutrition Products
Enteral Nutrition by Age
Enteral Nutrition for Patients aged 21 and older
Enteral Nutrition for Patients below 21 Years
Various Types of Enteral Feeding or Tube Feeding
What Constitutes Enteral Nutrition Diets?
Home-Made Diets
Commercial Enteral Formulas
Elemental Formulas
Oligomeric Formulas
Polymeric Formulas
Special Formulas
Pulmonary Formulas
Liver Formulas
Renal Formulas
Diabetes Formulas
Gastrointestinal Dysfunction Formulas
Immuno-modulatory Formulas
Enteral Nutrition in Patients with Acute Renal Failure (ARF)
Enteral Nutrition in Conservatively Treated Patients with Chronic Renal Failure (CRF)
Enteral Nutrition in Haemodialysis Patients
Enteral Nutrition in Chronic Ambulatory Peritoneal Dialysis (CAPD) Patients
Complications of Enteral Feeding
Complications Associated with Enteral Tube Feeding
Parenteral Nutrition
Sources of Parenteral Solutions
Routes of Administration
Types of Parenteral Nutrition Solutions
Total Parenteral Nutrition (TPN)
TPN Formulation
Partial Parenteral Nutrition (PPN)
Home Parenteral Nutrition
Parenteral Nutrition Formulations
Standard Solutions
Three-in-One Standard Bags
Two-in-one Standard Bags
Individual Solutions
Non-Standard Solutions
Classification of Parenteral Nutrition by Type of Nutrients
Amino Acids
Carbohydrates
Lipids
Minerals & Electrolytes
Micronutrients
Vitamins
Trace Elements
Large and Small Volume Parenteral Solutions
Large Volume Parenteral (LVP) Solutions
Small Volume Parenteral (SVP) Solutions
IV Fat Emulsions
Enabling Maintenance of Bodyweight
4. PRODUCT INNOVATIONS/INTRODUCTIONS/ APPROVALS
Otsuka Introduces HINE E-GEL Concentrated Liquid Nutrition Product
Alaska Introduces Friso 4 Infant Formula
Fresenius Kabi Obtains FDA Approval for Perikabiven® and Kabiven®
B. Braun Obtains FDA Approval for Nutrilipid® 20% for Parenteral Nutrition
Ingredion Europe Introduces UNI-PURE IMF 2332 and UNI-PURE IMF 8561 Infant Nutrition Product
Fonterra China to Launch Self-Branded Infant Formula in China
FDA Clears Fresenius Kabi for Emergency Import of Injectionable TPN Drugs
Marck Biosciences Receives MCC Approval for Six Pharma Products
Restore Health Pharmacy Launches High Quality Nutritional Supplement
Inergetics Introduces Surgex Ready to Drink Nutritional Beverage
Arla Foods Ingredients Introduces Revolutionary Whey Protein
Nestlé Health Science Rolls Out SpikeRight® PLUS for Enteral Safety
Claris Receives USFDA Approval for Marketing Products in the US
5. RECENT INDUSTRY ACTIVITY
Nestlé Sets Up Health Science Manufacturing Plant
Fonterra to Buy Stake in Beingmate
Fonterra Collaborates with Beingmate to Meet Infant Formula Demand
Baxter Recalls Select Lots of Parenteral Nutrition Products
ITH Pharma Recalls Lipid Phase Parenteral Nutrition Products
Unibrands and ICI to Market and Distribute Morinaga’s Infant Formula in Pakistan
Abbott Receives Approval for ENEVO Liquid for Enteral Use
Nestlé to Construct Infant Formula Plant in Mexico
Abbott Inaugurates Nutrition Production Facility in Haiti
Baxter Recalls Select Lots of Premix Parenteral Nutrition Products
Baxter Collaborates with JW Holdings for Omega 3 Lipids
Mead Johnson Establishes New Manufacturing and Research & Development Complex
Nestle Health Science Purchases Pamlab
Aspen Acquires IP Rights in Infant Nutritional Businesses of Nestlé
Danone Completes Acquisition of Wockhardt’s Nutrition Business
Abbott Nutrition Discontinues Enteral Device Business in the US and Puerto Rico
Danone Recalls Infant Formula Products in Asia
Yasheng Group Enters Joint Venture with IBC International LLC
Humana Establishes Offices in UAE
FDA Approves Clinolipid Lipid Injectable Emulsion
Nestle Acquires Pfizer Nutrition
Aperture Health Takes Over Triad Therapeutics
B Braun Acquires Nutrichem
Mead Johnson Nutrition Enters into Joint Venture with Sancor
Abbott Plans Collaboration with Syngene for Nutrition R&D Unit
AarhusKarlshamn Expands Capacity to Produce InFat
Abbott to Construct Nutrition Production Facility in Ohio
BioGaia Enters into a Collaboration Agreement with Nestlé
Claris Lifesciences Enters into JV with Otsuka Pharma and Mitsui for Indian Market
6. FOCUS ON SELECT GLOBAL PLAYERS
Abbott Nutrition (US)
American HomePatient, Inc. (US)
Baxter International, Inc. (US)
B. Braun Melsungen AG ( Germany)
Claris Lifesciences Ltd. ( India)
Groupe Danone ( France)
Nutricia North America (US)
Fresenius Kabi AG ( Germany)
Hospira, Inc. (US)
Mead Johnson Nutrition Company (US)
Meiji Co., Ltd. ( Japan)
Nestlé Health Science S.A ( Switzerland)
Otsuka Pharmaceutical Factory, Inc. ( Japan)
Sino-Swed Pharmaceutical Corp, Ltd. ( China)
7. GLOBAL MARKET PERSPECTIVETotal Companies Profiled: 64 (including Divisions/Subsidiaries 88)
The United States (27)
Canada (1)
Japan (7)
Europe (27)
France (5)
Germany (4)
The United Kingdom (4)
Italy (1)
Spain (1)
Rest of Europe (12)
Asia-Pacific (Excluding Japan) (23)
Latin America (3)
For more information visit http://www.researchandmarkets.com/research/d96jd4/clinical
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
SOURCE Research and Markets